Evidence map›Paper›PMID 23063561›Full record

ArticleStructure (London, England : 1993)2012

Structural and functional integration of the PLCγ interaction domains critical for regulatory mechanisms and signaling deregulation.

Tom D Bunney, Diego Esposito, Corine Mas-Droux, Ekatarina Lamber, Rhona W Baxendale, Marta Martins, Ambrose Cole, Dmitri Svergun, Paul C Driscoll, Matilda Katan

Open access · hybridAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. TCR Pathway Mutations in Mature T Cell Lymphomas.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Fibroblast growth factor receptor fusions in cancer: opportunities and challenges.Journal of experimental & clinical cancer research : CR · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Tom D BunneyInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Diego Esposito
Corine Mas-Droux
Ekatarina Lamber
Rhona W Baxendale
Marta Martins
Ambrose Cole
Dmitri Svergun
Paul C Driscoll
Matilda Katan
University College London · GBInstitute of Structural and Molecular Biology · GBBirkbeck, University of London · GBEuropean Molecular Biology Laboratory · DEResearch Institute of Molecular Pathology · AT

Funding

Medical Research Council MC_U117533887Medical Research Council MC_U117574559Medical Research Council U117574559
6 · The paper itself

Abstract

Multidomain proteins incorporating interaction domains are central to regulation of cellular processes. The elucidation of structural organization and mechanistic insights into many of these proteins, however, remain challenging due to their inherent flexibility. Here, we describe the organization and function of four interaction domains in PLCγ1 using a combination of structural biology and biochemical approaches. Intramolecular interactions within the regulatory region center on the cSH2 domain, the only domain that also interacts with the PLC-core. In the context of fibroblast growth-factor receptor signaling, the coordinated involvement of nSH2 and cSH2 domains mediates efficient phosphorylation of PLCγ1 resulting in the interruption of an autoinhibitory interface by direct competition and, independently, dissociation of PLCγ1 from the receptor. Further structural insights into the autoinhibitory surfaces provide a framework to interpret gain-of-function mutations in PLCγ isoforms linked to immune disorders and illustrate a distinct mechanism for regulation of PLC activity by common interaction domains.

Indexed as

Models, MolecularAmino Acid MotifsAmino Acid SubstitutionAnimalsCatalytic DomainCell LineCrystallography, X-RayEnzyme ActivationHumansInositol PhosphatesKineticsMutagenesis, Site-DirectedNuclear Magnetic Resonance, BiomolecularPhospholipase C gammaPhosphorylationProtein BindingFGFR1 protein, humanInositol PhosphatesPhospholipase C gammaPLCG1 protein, humanReceptor, Fibroblast Growth Factor, Type 1

Identifiers

PMID23063561
PMCPMC3532599
OpenAlexW2061677225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.